| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |